This site looks better in landscape mode
Skip to content
AKL
AKL Therapeutics
Developing a novel therapeutic for inflammatory diseases with a high unmet need
Developing a novel therapeutic for inflammatory diseases with a high unmet need
Over 50%
Over half of people diagnosed with knee osteoarthritis are under 65 years of age
